Evidence map›Paper›PMID 40559739›Full record

ArticleTropical medicine and infectious disease2025

Effectiveness of Pyrethroid-Piperonyl Butoxide Nets Versus Standard Pyrethroid-Only Nets in Preventing Malaria in Children Under 10 Years Living in Kisantu Health Zone, Democratic Republic of the Congo.

Gillon Ilombe, Joris Losimba Likwela, Philippe Lukanu, Aimée Lulebo, Nicole Muela, Joachim Mariën, Kennedy Makola Mbanzulu, Baby Mabanzila, Junior Rika Matangila, Fiacre Agossa and 6 more

Abstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Gillon IlombeNational Malaria Control Program (PNLP), Ministry of Health, 3040 Kinshasa I, Democratic Republic of the Congo.ORCID 0000-0001-5487-0798
Joris Losimba LikwelaSANRU Asbl-Primary Health Care in Rural Areas, Kinshasa 01015, Democratic Republic of the Congo.ORCID 0000-0002-2110-4488
Philippe LukanuSANRU Asbl-Primary Health Care in Rural Areas, Kinshasa 01015, Democratic Republic of the Congo.
Aimée LuleboPublic Health School, Faculty of Medicine, University of Kinshasa, 11850 Kinshasa I, Democratic Republic of the Congo.
Nicole MuelaProgramme Elargi de Vaccination (PEV), Ministry of Public Health, 3040 Kinshasa I, Democratic Republic of the Congo.
Joachim MariënEvolutionary Ecology Group, University of Antwerp, 2000 Antwerp, Belgium.ORCID 0000-0001-7023-445X
Kennedy Makola MbanzuluDepartment of Tropical Medicine, University of Kinshasa, 747 Kinshasa XI, Democratic Republic of the Congo.
Baby MabanzilaDepartment of Tropical Medicine, University of Kinshasa, 747 Kinshasa XI, Democratic Republic of the Congo.
Junior Rika MatangilaDepartment of Tropical Medicine, University of Kinshasa, 747 Kinshasa XI, Democratic Republic of the Congo.
Fiacre AgossaPMI VectorLink Project, Abt Associates Inc., 6130 Executive Blvd, Rockville, MD 20852, USA.ORCID 0000-0002-0763-6007
Eric MukomenaNational Malaria Control Program (PNLP), Ministry of Health, 3040 Kinshasa I, Democratic Republic of the Congo.
Sylvie LinsukeGlobal Health Institute, Faculty of Medicine, University of Antwerp, 2000 Antwerp, Belgium.ORCID 0000-0003-4283-0435
Albert KalonjiSANRU Asbl-Primary Health Care in Rural Areas, Kinshasa 01015, Democratic Republic of the Congo.
Pascal LutumbaDepartment of Tropical Medicine, University of Kinshasa, 747 Kinshasa XI, Democratic Republic of the Congo.
Jean-Pierre Van GeertruydenGlobal Health Institute, Faculty of Medicine, University of Antwerp, 2000 Antwerp, Belgium.ORCID 0000-0001-5006-6364
Seth R IrishGlobal Malaria Programme (GMP), World Health Organization (WHO), 1211 Genève, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Democratic Republic of the Congo (DRC) is among the countries that have a high malaria incidence. In an effort to combat this public health challenge, innovative tools and strategies are being developed and evaluated. Among the new generation of nets with improved effectiveness of insecticides, those treated with a combination of piperonyl butoxide (PBO) and pyrethroids appear to be a promising malaria control tool. This study evaluated the effectiveness of this combination under community conditions of use in the DRC. A quasi-experimental study was carried out from January to December 2018, in Kisantu Health Zone. Thirty villages were randomly allocated as clusters (1:1) to receive one of two types of long-lasting insecticidal nets (LLIN) treated with deltamethrin alone, or PBO with deltamethrin. After the intervention, the assessments were conducted monthly, quarterly, and every six months for malaria infection, mosquito density, and LLIN durability, respectively. Comparison of changes in different indices between the two groups was made using generalized linear models to correct for non-linear effects. A total of 1790 children were included. There was a significant non-linear effect of time (months) on the malaria infection incidence. The malaria infection incidence was higher in January-March, May-June, and November. It remained higher in the control group compared to the intervention group over time. Similarly, there was a significant non-linear effect of time on the density of both

Indexed as

Kisantu Health ZonePlasmodium infectionpreventing malariapyrethroid-piperonyl butoxide netsthe Democratic Republic of the Congo

Identifiers

PMID40559739
PMCPMC12197424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.